BETASERON NEEDLE-FREE SYRINGE Trademark
Trademark Overview
On Monday, July 22, 1996, a trademark application was filed for BETASERON NEEDLE-FREE SYRINGE with the United States Patent and Trademark Office. The USPTO has given the BETASERON NEEDLE-FREE SYRINGE trademark a serial number of 75137231. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 25, 1997. This trademark is owned by Schering Aktiengesellschaft. The BETASERON NEEDLE-FREE SYRINGE trademark is filed in the Medical Instrument Products category with the following description:
medical apparatus for dispensing pharmaceutical products
General Information
| Serial Number | 75137231 |
| Word Mark | BETASERON NEEDLE-FREE SYRINGE |
| Filing Date | Monday, July 22, 1996 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, August 25, 1997 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | medical apparatus for dispensing pharmaceutical products |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Schering Aktiengesellschaft |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | D-13342 Berlin
DE |
Trademark Events
| Event Date | Event Description |
| Monday, August 25, 1997 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, January 6, 1997 | NON-FINAL ACTION MAILED |
| Thursday, December 19, 1996 | ASSIGNED TO EXAMINER |
